Home › [Newsmaker] Samsung's first biosimilar drug gains domestic approval
 

Keywords :   


[Newsmaker] Samsung's first biosimilar drug gains domestic approval

2015-09-08 11:51:41| Biotech - Topix.net

Samsung Group, South Korea's leading conglomerate, has taken a significant step toward driving forward its newly-established biopharmaceuticals business, an emerging sector expected to become one of the company's future growth engines. Samsung Bioepis, the conglomerate's biotechnology research and development unit, said Monday that it had gained approval from the Ministry of Food and Drug Safety to begin selling Brenzys, its biosimilar copy of Pfizer's rheumatoid arthritis treatment Enbrel, in South Korea.

Tags: drug approval domestic gains

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
More »